These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3718681)

  • 1. Onset and growth rate of solid tumours derived from implanted ascites tumour cells pretreated with ascorbic acid.
    Liotti FS; Locci P
    Boll Ist Sieroter Milan; 1986; 65(1):61-4. PubMed ID: 3718681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of accumulation phenomena in normal and tumoral tissues of mice treated with ascorbic acid.
    Liotti FS; Talesa V; Menghini AR
    Int J Vitam Nutr Res; 1983; 53(3):251-7. PubMed ID: 6629664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Device for intracellular increase of oxygen free radicals and inhibition of MethA tumour cell proliferation: in vitro and in vivo studies.
    Mashiba H; Matsunaga K
    Int J Tissue React; 1988; 10(5):273-80. PubMed ID: 2855073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced inhibitory effects of hyperthermia combined with ascorbic acid on DNA synthesis in Ehrlich ascites tumor cells grown at a low cell density.
    Kageyama K; Onoyama Y; Otani S; Matsui-Yuasa I; Nagao N; Miwa N
    Cancer Biochem Biophys; 1995 Jan; 14(4):273-80. PubMed ID: 7767901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in anchorage-dependent growth and tumorigenicities between transformed C3H/10T 1/2 cells with morphologies that are or are not reverted to a normal phenotype by ascorbic acid.
    Benedict WF; Wheatley WL; Jones PA
    Cancer Res; 1982 Mar; 42(3):1041-5. PubMed ID: 7059969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulating effect of ascorbic acid on ascites tumor cell multiplication in vitro.
    Liotti FS; Bodo M; Talesa V
    J Cancer Res Clin Oncol; 1983; 106(1):69-70. PubMed ID: 6885899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ascorbic acid and 6-deoxy-6-chloro-ascorbic acid: potential anticancer drugs.
    Osmak M; Kovacek I; Ljubenkov I; Spaventi R; Eckert-Maksić M
    Neoplasma; 1997; 44(2):101-7. PubMed ID: 9201289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmented inhibition of tumor cell proliferation in the combined use of disulfiram with ascorbic acid and the involvement of oxygen free radicals.
    Mashiba H; Matsunaga K
    Jpn J Exp Med; 1990 Aug; 60(4):209-14. PubMed ID: 2292808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ascorbic and dehydroascorbic acid on the multiplication of tumor ascites cells in vitro.
    Liotti FS; Menghini AR; Guerrieri P; Talesa V; Bodo M
    J Cancer Res Clin Oncol; 1984; 108(2):230-2. PubMed ID: 6470029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis reveals upregulation of RKIP in S-180 implanted BALB/C mouse after treatment with ascorbic acid.
    Park S; Ahn ES; Lee S; Jung M; Park JH; Yi SY; Yeom CH
    J Cell Biochem; 2009 Apr; 106(6):1136-45. PubMed ID: 19224539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects and transport kinetics of ascorbate derivatives in leukemic cell lines.
    Koh WS; Lee SJ; Lee H; Park C; Park MH; Kim WS; Yoon SS; Park K; Hong SI; Chung MH; Park CH
    Anticancer Res; 1998; 18(4A):2487-93. PubMed ID: 9703897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Avemar and Avemar + vitamin C on tumor growth and metastasis in experimental animals.
    Hidvégi M; Ráso E; Tömösközi-Farkas R; Paku S; Lapis K; Szende B
    Anticancer Res; 1998; 18(4A):2353-8. PubMed ID: 9703878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of tumour size on the in vivo growth inhibition of human colon carcinoma cells (HT-29) by colon mitosis inhibitor.
    Paulsen JE; Elgjo K
    In Vivo; 2001; 15(5):397-401. PubMed ID: 11695236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemo-immunotherapeutical studies on Dalton's lymphoma in mice using cisplatin and ascorbic acid: synergistic antitumor effect in vivo and in vitro.
    Sarna S; Bhola RK
    Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):327-33. PubMed ID: 8010874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
    Lincoln DT; Singal PK; Al-Banaw A
    Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ascorbic acid is a potent inhibitor of various forms of T cell apoptosis.
    Campbell JD; Cole M; Bunditrutavorn B; Vella AT
    Cell Immunol; 1999 May; 194(1):1-5. PubMed ID: 10357874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular stroma-derived endothelial colony forming progenitor cells adapt to tumour growth.
    Lincoln DT; Kaiser HE; Abul HT; al-Jarallah MA
    In Vivo; 2002; 16(6):479-92. PubMed ID: 12494892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biological activity of urocanic acid].
    Burobin VA; Ponomareva OV; Nikolaeva TG; Iurchenko NIa
    Vopr Med Khim; 1985; 31(1):102-6. PubMed ID: 3984264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. II. Suppression of T-cell cytotoxicity by pretreatment of mice with subimmunogenic doses of tumour cells.
    Cihak J; Ziegler HW; Kölsch E
    Immunology; 1981 May; 43(1):145-52. PubMed ID: 6972902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ascorbic acid-independent synthesis of collagen in mice.
    Parsons KK; Maeda N; Yamauchi M; Banes AJ; Koller BH
    Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1131-9. PubMed ID: 16352673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.